Article info

Download PDFPDF
MG-134 Update on novel treatments for pyridoxine-dependent epilepsy due to antiquitin deficiency

Authors

  • Clara DM van Karnebeek 1Division of Biochemical Diseases; Department of Pediatrics; Treatable Intellectual Disability Endeavour in British Columbia (Www.tidebc.org); BC Children’s Hospital, University of British Columbia, Vancouver, B. C. Canada PubMed articlesGoogle scholar articles
  • W Al-Hertani 2Department of Human Genetics, McGill University Health Centre, Montreal QC, Canada PubMed articlesGoogle scholar articles
  • S Jaggumantri 1Division of Biochemical Diseases; Department of Pediatrics; Treatable Intellectual Disability Endeavour in British Columbia (Www.tidebc.org); BC Children’s Hospital, University of British Columbia, Vancouver, B. C. Canada PubMed articlesGoogle scholar articles
  • C Coughlin 3The Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, USA PubMed articlesGoogle scholar articles
  • S Stockler 1Division of Biochemical Diseases; Department of Pediatrics; Treatable Intellectual Disability Endeavour in British Columbia (Www.tidebc.org); BC Children’s Hospital, University of British Columbia, Vancouver, B. C. Canada PubMed articlesGoogle scholar articles
  • H Hans Hartmann 4Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany PubMed articlesGoogle scholar articles
  • J Van Hove 3The Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, USA PubMed articlesGoogle scholar articles

Citation

van Karnebeek CD, Al-Hertani W, Jaggumantri S, et al
MG-134 Update on novel treatments for pyridoxine-dependent epilepsy due to antiquitin deficiency

Publication history

  • First published December 4, 2015.
Online issue publication 
April 27, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.